HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis.
HeberNasvac 是一种用于治疗慢性乙型肝炎的治疗性疫苗，可刺激先天免疫的局部和全身标志物：在 SARS-CoV-2 暴露后预防中具有潜在用途
期刊:Euroasian J Hepatogastroenterol
影响因子:0.000
doi:10.5005/jp-journals-10018-1344
Fleites Yoel A, Aguiar Jorge, Cinza Zurina, Bequet Monica, Marrero Elieser, VizcaÃno Maritania, Esquivel Idelsis, Diaz Marisol, Sin-Mayor Adriana, Garcia Maura, Martinez Sara M, Beato Abrahan, Galarraga Ana G, Mendoza-Mari Yssel, Valdés Iris, GarcÃa Gerardo, Lemos Gilda, González Isabel, Canaán-Haden Camila, Figueroa Nelvis, Oquendo Rachel, Akbar Sheikh Mf, Mahtab Mamun A, Uddin Mohammad H, Guillén Gerardo E, Muzio Verena L, Pentón Eduardo, Aguilar Julio C
